Latest Articles

Publication Date
AstraZeneca Imfinzi regimen for endometrial cancer gains FDA approval - Pharmaceutical Technology

AstraZeneca Imfinzi regimen for endometrial cancer gains FDA approval Pharmaceutical Technology

Published: June 17, 2024, 7 a.m.
FDA Approves Durvalumab Combination for Advanced or Recurrent Endometrial Cancer - Oncology News Central

FDA Approves Durvalumab Combination for Advanced or Recurrent Endometrial Cancer Oncology News Central

Published: June 17, 2024, 7 a.m.
AstraZeneca’s Imfinzi regimen granted FDA approval to treat endometrial cancer - PMLiVE

AstraZeneca’s Imfinzi regimen granted FDA approval to treat endometrial cancer PMLiVE

Published: June 17, 2024, 7 a.m.
FDA Approves AstraZeneca’s Imfinzi for Mismatch Repair Deficient Primary Advanced or Recurrent Endometrial Cancer - Pharmaceutical Executive

FDA Approves AstraZeneca’s Imfinzi for Mismatch Repair Deficient Primary Advanced or Recurrent Endometrial Cancer Pharmaceutical Executive

Published: June 17, 2024, 7 a.m.
Film screening in Cork aims to highlight the problems in treatment for Endometriosis - EchoLive.ie

Film screening in Cork aims to highlight the problems in treatment for Endometriosis EchoLive.ie

Published: June 14, 2024, 7 a.m.
Dr. Grace Janik Receives Prestigious Society of Reproductive Surgeons Award - Milwaukee Magazine

Dr. Grace Janik Receives Prestigious Society of Reproductive Surgeons Award Milwaukee Magazine

Published: June 14, 2024, 7 a.m.
Relugolix combination therapy effective, safe for premenopausal women with endometriosis - Healio

Relugolix combination therapy effective, safe for premenopausal women with endometriosis Healio

Published: June 11, 2024, 7 a.m.
ROSE Study Enters Its Second Decade with Significant Progress and Hope for Endometriosis Patients - Endometriosis Foundation of America - The Blossom

ROSE Study Enters Its Second Decade with Significant Progress and Hope for Endometriosis Patients Endometriosis Foundation of America - The Blossom

Published: June 11, 2024, 7 a.m.
Upregulation of sperm-associated antigen 5 expression in endometrial carcinoma was associated with poor prognosis and immune dysregulation, and promoted cell migration and invasion - Nature.com

Upregulation of sperm-associated antigen 5 expression in endometrial carcinoma was associated with poor prognosis and immune dysregulation, and promoted cell migration and invasion Nature.com

Published: June 11, 2024, 7 a.m.
Effect of Oral Contraceptive Use in Relation to Fertile Years on the Risk of Endometriosis in Women with Primary Infertility: A Ten-Year Single-Centre Retrospective Analysis.

Background and Objectives: Oral contraceptives (OCs) are usually used to treat endometriosis; however, the evidence is inconsistent about whether OC use in the past, when given to asymptomatic women, is …

Published: June 10, 2024, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!